Event Sponsors:
The Israeli Association for the Study of Diabetes (IASD)
|
What would you like to see?
Scientific program |
Posters exhibition |
Important deadline |
Local Organizing Committee (Loc) |
Scientific Committee |
Registration |
Sponsors |
Conference secretariat |
Map
Scientific program
To download the scientific program, click here
|
8:00 – 8:50
|
Reception and Registration
|
|
8:50 – 9:00
|
OPENING AND GREETINGS:
Sarah Ferber - Conference Chairman
Zeev Rotstein- Director, Sheba Medical Center, Ramat-Gan, Israel
|
|
SESSION 1
|
Reprogramming of adult cells into committed lineages
Chairpersons – Michael Walker, Sarah Ferber
|
|
9:00 – 9:25
|
Reprogramming liver cells into insulin-producing cells by pancreatic transcription factors
Li-Jun Yang, University of Florida, Gainsville, FL, USA
|
|
9:25 – 9:50
|
Reprogramming into pancreatic beta cells based on developmental cues, converting alpha to beta cells
Patrick Collombat, INSERM, Nice, France
|
|
9:50 – 10:10
|
Ex-vivo expansion of adult human pancreatic islet beta cells
Shimon Efrat, Tel-Aviv University, Tel-Aviv, Israel
|
|
10:10 – 10:25
|
Hierarchical sequential administration of pancreatic transcription factors that leads to pancreas organogenesis improves liver to pancreas reprogramming process
Dana Berneman, Sheba Medical Center, Ramat-Gan, Israel and Tel-Aviv University, Tel Aviv, Israel
|
|
10:25 – 10:45
|
COFFEE BREAK
|
|
10:45 – 11:10
|
Gene transfer to induce cellular reprogramming for the treatment of diabetes
Mark Kay, Stanford University, CA, USA
|
|
11:10 – 11:35
|
AAV vectors for gene therapy of the brain in lysosomal storage diseases
Jean Michel Heard, Institut Pasteur, INSERM, Paris, France
|
|
11:35 – 11:55
|
Delineating the molecular mechanisms regulating chromatin protein dynamics in embryonic stem cells
Eran Meshorer, The Hebrew University, Jerusalem, Israel
|
|
11:55 - 12:10
|
Homing endonucleases for gene therapy
Adi Barzel, Tel-Aviv University, Tel-Aviv, Israel
|
|
12:10 - 13:10
|
LUNCH BREAK and POSTER SESSION
|
|
SESSION 2
|
TISSUE AND CELL THERAPY
Chairpersons – Moshe Flugelman, Shulamit Levenberg
|
|
13:10 – 13:30
|
hESC – from bench to patient
Benjamin Reubinoff, Hadassah Hebrew University Hospital, Jerusalem, Israel
|
|
13:30 – 13:50
|
Differentiated mesenchymal stem cells rescue sciatic nerve injury in rats
Daniel Offen, Tel-Aviv University, Tel-Aviv, Israel
and Rabin Medical Center, Petach-Tikva, Israel
|
|
13:50 – 14:10
|
Targeting CEACAM1 in adoptive TIL transfer in melanoma
Gal Markel, Sheba Medical Center, Ramat-Gan, Israel and Tel-Aviv University, Tel-Aviv, Israel
|
|
14:10 – 14:30
|
Engineering cell platforms for cardiovascular regeneration
Marcelle Machluf, Technion-IIT, Haifa, Israel
|
|
14:30 - 14:45
|
Efficient transgene expression from naked DNA delivered into an arterio-venous fistula model for kidney dialysis
Anat Globerman, Hadassah University Hospital, Jerusalem, Israel
|
|
14:45 - 15:05
|
COFFEE BREAK
|
|
SESSION 3
|
STEM CELLS
Chairpersons: Smadar Cohen, Benjamin Dekel
|
|
15:05 – 15:25
|
Identification and prospective isolation of novel human renal stem/progenitor populations from normal and cancerous kidney tissue
Benjamin Dekel, Sheba Medical Center, Ramat-Gan, Israel and Tel-Aviv University, Tel-Aviv, Israel
|
|
15:25 – 15:40
|
An NCAM1+ cell enriched for aldeheyde dehydrogenase activity and possessing renal stem cell characteristics is the Wilms’ tumor initiating cell
Naomi Pede-Shakked, Sheba Medical Center, Ramat-Gan, Israel and Tel-Aviv University, Tel-Aviv, Israel
|
|
15:40 – 16:00
|
Dynamic interactions between the nervous and immune systems with the microenvironment, regulate normal and leukemic human stem cells
Tsvee Lapidot, Weizmann Institute of Science, Rehovot, Israel
|
|
16:00 – 16:20
|
Clinical and future application of autologous multipotential mesenchymal stromal stem cells for the treatment of neurological diseases
Shimon Slavin, International Center for Cell Therapy & Cancer Immunotherapy (CTCI), Tel-Aviv, Israel
|
|
